Analystreport

Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $64.00 price target on the stock.

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com